Author Correction: Immune reconstitution therapies: concepts for durable remission in multiple sclerosis

Affiliations

¹ Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster, Germany. jan.luenemann@ukmuenster.de.
² Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster, Germany.
³ Department of Medicine, Division of Brain Sciences, Imperial College London, London, UK.
⁴ Department of Neurology and Center for Neuroinflammation and Experimental Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

^# Contributed equally.

Published Erratum

Jan D Lünemann et al. Nat Rev Neurol. 2020 Feb.

. 2020 Feb;16(2):125.

doi: 10.1038/s41582-020-0310-1.

¹ Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster, Germany. jan.luenemann@ukmuenster.de.
² Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster, Germany.
³ Department of Medicine, Division of Brain Sciences, Imperial College London, London, UK.
⁴ Department of Neurology and Center for Neuroinflammation and Experimental Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

^# Contributed equally.

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Immune reconstitution therapies: concepts for durable remission in multiple sclerosis.
Lünemann JD, Ruck T, Muraro PA, Bar-Or A, Wiendl H. Lünemann JD, et al. Nat Rev Neurol. 2020 Jan;16(1):56-62. doi: 10.1038/s41582-019-0268-z. Epub 2019 Oct 24. Nat Rev Neurol. 2020. PMID: 31649335 Review.